Business

Pipeline Expanded with Proprietary Injectable Antipsychotic

Pipeline Expanded with Proprietary Injectable Antipsychotic

Patrys LimitedNovember 25, 20254

Pipeline Expanded with Proprietary Injectable Antipsychotic

About this update from Patrys Limited

Patrys Ltd has released a press release. View Attachment

View stock analysis, news, and events for Patrys Limited

More from Patrys Limited

Ethics Approval Secured for Phase 1A Clinical Trial

August 27, 2026

Investor Presentation - TechKnow Invest Roadshow

July 26, 2026

All Patrys Limited news →